Safety and immunogenicity of the epicutaneous reactivation of pertussis toxin immunity in healthy adults: a phase I, randomized, double-blind, placebo-controlled trialOlga Chatzis, Claire‐Anne Siegrist, Géraldine Blanchard‐Rohner et al.|Clinical Microbiology and Infection|2020Cited by 14
SARS-CoV-2 Transmission in Belgian French-Speaking Primary Schools: An Epidemiological Pilot StudyJulie Frère, Dimitri Van der Linden, Nathalie Ribesse et al.|Viruses|2022Cited by 2
National real-life impact of prevention with nirsevimab on infants’ RSV hospitalizations in BelgiumSophie Blumental, Marc Raes, Adrien Lajot et al.|BMC Infectious Diseases|2026Cited by 0